Clinical Trial Update: Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED